{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-060258","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.363715+00:00","generated_at":"2026-06-13T00:48:09.101826+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vicarious Surgical Q2 2023 net loss $15.3M; expects first human procedure mid-2024","bullets":["GAAP net loss $15.3M ($0.12/sh) vs $1.5M ($0.01/sh) YoY; adjusted net loss $20.4M ($0.16/sh).","Cash and investments $82.8M; quarterly burn $14.9M; FY 2023 cash burn guidance $55-$65M unchanged.","FDA clarity on regulatory pathway; first ventral hernia procedure planned for mid-2024.","Design freeze of V1.0 system completed April; integration on track for fall 2023.","Signed fourth major U.S. hospital system agreement, covering over 250 hospitals; promoted John Mazzola to COO."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-060258","json":"https://secwatch.observer/filing/0001213900-23-060258.json","markdown":"https://secwatch.observer/filing/0001213900-23-060258.md","text":"https://secwatch.observer/filing/0001213900-23-060258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023060258/0001213900-23-060258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023060258/ea182423-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:48:09.101826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc78cf063a62b3610f6ea6c46382362cfae221a3","claim":"Vicarious Surgical Inc. reported second quarter ended June 30, 2023 results: net income $15.3 million, EPS $0.12.","evidence_excerpt":"GAAP net loss for the second quarter was $15.3 million, equating to a net loss per share of $0.12, as compared to a GAAP net loss of $1.5 million, equating to a net loss per share of $0.01 for the same period of the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023060258/0001213900-23-060258-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Net income","value":"$15.3 million"},{"label":"EPS","value":"$0.12"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}